Literature DB >> 451565

Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo.

M Chorev, R Shavitz, M Goodman, S Minick, R Guillemin.   

Abstract

The synthesis of four enkephalinamide analogs is described in which the peptide bond between residues 4 and 5 is reversed with or without simultaneous reversal of the carboxyl-terminal amide bond. These so-called partially modified retro-inverso-isomers are new, potent, topochemical analogs of the enkephalins. Tests, both in vitro and in vivo, have shown that these analogs are considerably longer acting than any previously studied enkephalins. Thus, partial reversal of the peptide bonds of the backbone can result in peptides with enhanced activity compared to a parent compound, provide that the structural complementarity of both the side chains and end groups are conserved.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 451565     DOI: 10.1126/science.451565

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

1.  Computational and spectroscopic data correlation study of N,N'-bisarylmalonamides (Part II).

Authors:  Violeta M Arsovski; Bojan Đ Božić; Jelena M Mirković; Vesna D Vitnik; Željko J Vitnik; Slobodan D Petrović; Gordana S Ušćumlić; Dušan Ž Mijin
Journal:  J Mol Model       Date:  2015-08-21       Impact factor: 1.810

2.  Spectroscopic and quantum mechanical investigation of N,N'-bisarylmalonamides: solvent and structural effects.

Authors:  Violeta M Arsovski; Bojan Đ Božić; Jelena M Mirković; Vesna D Vitnik; Zeljko J Vitnik; Walter M F Fabian; Slobodan D Petrović; Dušan Z Mijin
Journal:  J Mol Model       Date:  2014-08-14       Impact factor: 1.810

3.  Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.

Authors:  B P Roques; E Lucas-Soroca; P Chaillet; J Costentin; M C Fournié-Zaluski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

4.  Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.

Authors:  Maria Vincenza Carriero; Katia Bifulco; Vincenzo Ingangi; Susan Costantini; Giovanni Botti; Concetta Ragone; Michele Minopoli; Maria Letizia Motti; Domenica Rea; Giosuè Scognamiglio; Gerardo Botti; Claudio Arra; Gennaro Ciliberto; Antonello Pessi
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.